Cargando…
Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential IκB kinase β inhibitors for the treatment of pancreatic cancer
Given the important role that inhibitory kappa B (IκB) kinase β (IKKβ) plays in pancreatic cancer (PC) development and progression, inhibitors targeting IKKβ are believed to be increasingly popular as novel anti-PC therapies. Two synthetic molecules, named EF24 and EF31, exhibited favorable potentia...
Autores principales: | Xie, Xuemeng, Tu, Jinfu, You, Heyi, Hu, Bingren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440027/ https://www.ncbi.nlm.nih.gov/pubmed/28553074 http://dx.doi.org/10.2147/DDDT.S133172 |
Ejemplares similares
-
A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies
por: Bisht, Savita, et al.
Publicado: (2016) -
The curcumin analog EF24 is a novel senolytic agent
por: Li, Wen, et al.
Publicado: (2019) -
Bioactivities of EF24, a Novel Curcumin Analog: A Review
por: He, Yonghan, et al.
Publicado: (2018) -
In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin Analog
por: Liu, Haitao, et al.
Publicado: (2012) -
Similarities and Differences Between HFmrEF and HFpEF
por: Li, Peixin, et al.
Publicado: (2021)